Analyst Ratings for Prevail Therapeutics (PRVL)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/23/2020 | Wedbush | Laura Chico | Downgrade | Neutral (Outperform) |
22.00 (N/A) |
23.15 (23.00) |
-0.65% | Details |
| 12/17/2020 | Stifel | Paul Matteis | Downgrade | Hold (Buy) |
23.00 (N/A) |
22.75 (23.00) |
1.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
